S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.43 (+0.51%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
Log in

Chardan Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Chardan Capital. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Chardan Capital.

DateBrokerageActionCompanyRatingPrice TargetImpact on PriceActions
12/2/2019Chardan CapitalReiteratesVistagen Therapeutics (VTGN)NeutralHigh    
12/2/2019Chardan CapitalReiteratesMinerva Neurosciences (NERV)BuyHigh    
12/4/2019Chardan CapitalReiteratesAudentes Therapeutics (BOLD)Buy -> Neutral $60.00Low    
12/2/2019Chardan CapitalReiteratesKodiak Sciences (KOD)Buy $40.00High    
11/29/2019Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)Buy$45.00 -> $81.00Medium    
11/27/2019Chardan CapitalInitiatesOcugen (OCGN)Buy $2.00High    
11/26/2019Chardan CapitalDowngradesThe Medicines (MDCO)Buy -> NeutralLow    
11/25/2019Chardan CapitalReiteratesThe Medicines (MDCO)Buy -> Buy $85.00Low    
11/25/2019Chardan CapitalReiteratesTocagen (TOCA)HoldHigh    
11/21/2019Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)Buy $33.00High    
11/19/2019Chardan CapitalReiteratesThe Medicines (MDCO)Buy $100.00Low    
11/18/2019Chardan CapitalReiteratesCrispr Therapeutics (CRSP)Buy $72.50High    
11/15/2019Chardan CapitalReiteratesOncoCyte (OCX)Buy $7.75N/A    
11/14/2019Chardan CapitalUpgradesVascular Biogenics (VBLT)Neutral -> Buy $3.25High    
11/13/2019Chardan CapitalReiteratesKodiak Sciences (KOD)Buy $40.00High    
11/13/2019Chardan CapitalReiteratesTocagen (TOCA)Hold $1.00High    
11/10/2019Chardan CapitalReiteratesCatalyst Biosciences (CBIO)Buy $25.00Low    
11/8/2019Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)Buy $33.00High    
11/7/2019Chardan CapitalReiteratesEmergent Biosolutions (EBS)Buy $71.00High    
11/5/2019Chardan CapitalInitiatesRocket Pharmaceuticals (RCKT)Buy $30.00High    
11/3/2019Chardan CapitalReiteratesVistagen Therapeutics (VTGN)Hold $0.70Low    
10/28/2019Chardan CapitalRaises TargetAxovant Gene Therapies (AXGT)Buy$10.00 -> $15.00Low    
10/24/2019Chardan CapitalReiteratesReplimune Group (REPL)Buy $28.00Low    
10/23/2019Chardan CapitalInitiatesPDS Biotechnology (PDSB)Buy $10.00High    
10/21/2019Chardan CapitalSet Price TargetCrispr Therapeutics (CRSP)Buy $72.50Low    
10/23/2019Chardan CapitalReiteratesProvention Bio (PRVB)Buy $18.50Medium    
10/22/2019Chardan CapitalRaises TargetArrowhead Pharmaceuticals (ARWR)Buy$32.00 -> $45.00High    
10/15/2019Chardan CapitalSet Price TargetReplimune Group (REPL)Buy $28.00High    
10/15/2019Chardan CapitalReiteratesCrispr Therapeutics (CRSP)Buy $72.50Low    
10/15/2019Chardan CapitalRaises TargetKodiak Sciences (KOD)Buy$22.50 -> $35.00High    
10/15/2019Chardan CapitalRaises TargetAdverum Biotechnologies (ADVM)Neutral$6.00 -> $10.00High    
10/11/2019Chardan CapitalReiteratesProQR Therapeutics (PRQR)Buy $25.00High    
10/6/2019Chardan CapitalReiteratesAudentes Therapeutics (BOLD)Buy $50.00Low    
10/4/2019Chardan CapitalDowngradesArbutus Biopharma (ABUS)Buy -> NeutralHigh    
10/3/2019Chardan CapitalDowngradesTocagen (TOCA)Hold $1.00High    
9/30/2019Chardan CapitalSet Price TargetArcimoto (FUV)Buy $10.00High    
10/1/2019Chardan CapitalReiteratesMinerva Neurosciences (NERV)Buy $17.00High    
9/27/2019Chardan CapitalSet Price TargetIntellia Therapeutics (NTLA)Buy $57.50High    
9/27/2019Chardan CapitalInitiatesChardan Healthcare Acquisition (CHAC)Buy $28.00High    
9/25/2019Chardan CapitalInitiatesMinerva Neurosciences (NERV)Buy $17.00Low    
9/19/2019Chardan CapitalReiteratesSynlogic (SYBX)BuyHigh    
9/19/2019Chardan CapitalReiteratesProvention Bio (PRVB)BuyMedium    
9/19/2019Chardan CapitalReiteratesKaleido Biosciences (KLDO)BuyMedium    
9/19/2019Chardan CapitalReiteratesImmunic (IMUX)BuyMedium    
9/19/2019Chardan CapitalReiteratesEvelo Biosciences (EVLO)NeutralHigh    
9/19/2019Chardan CapitalReiteratesAssembly Biosciences (ASMB)NeutralHigh    
9/23/2019Chardan CapitalReiteratesMeiraGTx (MGTX)Buy $45.00Low    
9/19/2019Chardan CapitalReiteratesSeres Therapeutics (MCRB)BuyLow    
9/18/2019Chardan CapitalReiteratesIVERIC bio (ISEE)Hold $1.25Low    
9/15/2019Chardan CapitalReiteratesModerna (MRNA)BuyLow    
9/13/2019Chardan CapitalDowngradesTocagen (TOCA)Buy -> Neutral $1.00High    
9/13/2019Chardan CapitalLowers TargetAdverum Biotechnologies (ADVM)Neutral$10.00 -> $6.00High    
9/6/2019Chardan CapitalSet Price TargetImmunic (IMUX)Buy $40.00Low    
9/3/2019Chardan CapitalSet Price TargetEmergent Biosolutions (EBS)Buy $71.00Low    
9/4/2019Chardan CapitalSet Price TargetRegenxbio (RGNX)Buy $150.00Low    
9/5/2019Chardan CapitalReiteratesArcimoto (FUV)Buy $10.00High    
8/30/2019Chardan CapitalSet Price TargetMesoblast (MESO)Hold $6.00Low    
9/3/2019Chardan CapitalReiteratesUniqure (QURE)BuyMedium    
9/3/2019Chardan CapitalUpgradesApplied Genetic Technologies (AGTC)Neutral -> Buy $7.50Low    
9/3/2019Chardan CapitalRaises TargetAudentes Therapeutics (BOLD)Buy$40.00 -> $50.00High    
8/26/2019Chardan CapitalSet Price TargetThe Medicines (MDCO)Buy $90.00Low    
8/22/2019Chardan CapitalReiteratesLineage Cell Therapeutics (LCTX)BuyLow    
8/22/2019Chardan CapitalReiteratesSunworks (SUNW)NeutralLow    
8/25/2019Chardan CapitalSet Price TargetCatalyst Biosciences (CBIO)Buy $25.00High    
8/25/2019Chardan CapitalSet Price TargetInVitae (NVTA)Buy $32.00High    
8/23/2019Chardan CapitalLowers TargetTivity Health (TVTY)Buy$33.00 -> $24.00High    
8/21/2019Chardan CapitalSet Price TargetRegenxbio (RGNX)Buy $150.00Medium    
8/22/2019Chardan CapitalReiteratesBenefitfocus (BNFT)Hold $27.00High    
8/15/2019Chardan CapitalReiteratesLa Jolla Pharmaceutical (LJPC)BuyHigh    
8/16/2019Chardan CapitalSet Price TargetProQR Therapeutics (PRQR)Buy $25.00High    
8/19/2019Chardan CapitalReiteratesAdverum Biotechnologies (ADVM)Hold $10.00Medium    
8/16/2019Chardan CapitalInitiatesLivongo Health (LVGO)Neutral$40.00 -> $40.00High    
8/16/2019Chardan CapitalUpgradesSolid Biosciences (SLDB)Neutral -> Buy$7.50 -> $10.00High    
8/15/2019Chardan CapitalReiteratesLogicBio Therapeutics (LOGC)Buy $20.00Medium    
8/15/2019Chardan CapitalReiteratesReplimune Group (REPL)Buy $28.00Medium    
8/13/2019Chardan CapitalReiteratesVascular Biogenics (VBLT)Hold $3.00High    
8/13/2019Chardan CapitalReiteratesDicerna Pharmaceuticals (DRNA)Buy $18.00Medium    
8/12/2019Chardan CapitalInitiatesImmunic (IMUX)Buy $40.00Medium    
8/7/2019Chardan CapitalReiteratesAssembly Biosciences (ASMB)Hold $30.00High    
8/5/2019Chardan CapitalReiteratesKVH Industries (KVHI)Buy $20.00High    
7/29/2019Chardan CapitalReiteratesVistagen Therapeutics (VTGN)NeutralHigh    
7/29/2019Chardan CapitalReiteratesLogicBio Therapeutics (LOGC)BuyMedium    
7/25/2019Chardan CapitalReiteratesEditas Medicine (EDIT)Buy $55.00Medium    
7/25/2019Chardan CapitalReiteratesDmc Global (BOOM)Buy $79.00Medium    
7/23/2019Chardan CapitalReiteratesSmith Micro Software (SMSI)Buy $5.00High    
7/21/2019Chardan CapitalSet Price Target22nd Century Group (XXII)Buy $12.00N/A    
7/21/2019Chardan CapitalSet Price TargetFORESIGHT AUTON/S (FRSX)Buy $7.00N/A    
7/23/2019Chardan CapitalInitiatesPhreesia (PHR)Buy -> Buy $33.00Low    
7/23/2019Chardan CapitalInitiatesReplimune Group (REPL)Buy -> Buy $28.00Low    
7/22/2019Chardan CapitalDowngradesVistagen Therapeutics (VTGN)Buy -> Neutral$22.00 -> $0.70High    
7/15/2019Chardan CapitalSet Price TargetSynlogic (SYBX)Buy $25.00High    
7/16/2019Chardan CapitalReiteratesArbutus Biopharma (ABUS)Buy $5.00High    
7/12/2019Chardan CapitalSet Price TargetFORESIGHT AUTON/S (FRSX)Buy $7.00Low    
7/11/2019Chardan CapitalInitiatesImmunic (IMUX)Buy -> Buy $40.00High    
7/3/2019Chardan CapitalSet Price TargetArcimoto (FUV)Buy $10.00Low    
7/2/2019Chardan CapitalReiteratesVuzix (VUZI)Buy $10.00Medium    
7/1/2019Chardan CapitalUpgradesHMS (HMSY)Neutral -> Buy$37.00 -> $41.00Medium    
6/30/2019Chardan CapitalReiteratesAssembly Biosciences (ASMB)HoldHigh    
6/30/2019Chardan CapitalSet Price TargetFORESIGHT AUTON/S (FRSX)Buy $7.00High    
6/27/2019Chardan CapitalSet Price TargetGenius Brands International (GNUS)Buy $8.00High    
6/24/2019Chardan CapitalSet Price TargetLa Jolla Pharmaceutical (LJPC)Buy $20.00Low    
6/24/2019Chardan CapitalRaises TargetKrystal Biotech (KRYS)Buy$57.50 -> $75.00High    
6/20/2019Chardan CapitalSet Price TargetArcturus Therapeutics (ARCT)Buy $18.00High    
6/20/2019Chardan CapitalSet Price TargetArcimoto (FUV)Buy $10.00Medium    
6/18/2019Chardan CapitalReiteratesRegenxbio (RGNX)Buy -> Buy$145.00 -> $150.00Medium    
6/16/2019Chardan CapitalSet Price TargetEditas Medicine (EDIT)Buy $55.00Medium    
6/17/2019Chardan CapitalReiteratesSeres Therapeutics (MCRB)BuyLow    
6/12/2019Chardan CapitalSet Price TargetArcimoto (FUV)Buy $10.00High    
6/13/2019Chardan CapitalReiteratesKodiak Sciences (KOD)Buy $22.50Low    
6/12/2019Chardan CapitalReiteratesWrap Technologies (WRTC)Buy $12.50High    
6/11/2019Chardan CapitalReiteratesInVitae (NVTA)Buy $30.00High    
6/10/2019Chardan CapitalInitiatesProvention Bio (PRVB)Buy $20.00High    
6/7/2019Chardan CapitalSet Price TargetCrispr Therapeutics (CRSP)Buy $73.00High    
6/5/2019Chardan CapitalReiteratesRegenxbio (RGNX)Buy -> Buy$127.50 -> $145.00Low    
5/31/2019Chardan CapitalSet Price TargetMesoblast (MESO)Hold $6.00Medium    
6/2/2019Chardan CapitalReiteratesModerna (MRNA)Buy $40.00High    
5/31/2019Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)Buy $30.00High    
5/28/2019Chardan CapitalReiteratesIntellia Therapeutics (NTLA)Buy $57.50Low    
5/23/2019Chardan CapitalReiteratesFORESIGHT AUTON/S (FRSX)Buy $7.25Low    
5/22/2019Chardan CapitalReiteratesTocagen (TOCA)Buy $10.00High    
5/20/2019Chardan CapitalReiteratesModel N (MODN)Buy $23.00Low    
5/20/2019Chardan CapitalSet Price TargetIovance Biotherapeutics (IOVA)Buy $30.00Medium    
5/17/2019Chardan CapitalSet Price TargetOncoCyte (OCX)Buy $8.00N/A    
5/17/2019Chardan CapitalReiteratesKamada (KMDA)Buy $7.00Low    
5/16/2019Chardan CapitalReiteratesVascular Biogenics (VBLT)Hold $3.00High    
5/15/2019Chardan CapitalReiteratesFORESIGHT AUTON/S (FRSX)BuyLow    
5/15/2019Chardan CapitalReiteratesContraFect (CFRX)Buy $1.50High    
5/14/2019Chardan CapitalSet Price TargetTocagen (TOCA)Buy $25.00Low    
5/14/2019Chardan CapitalSet Price TargetKVH Industries (KVHI)Buy $20.00Low    
5/14/2019Chardan CapitalReiteratesMeiraGTx (MGTX)BuyHigh    
5/14/2019Chardan CapitalDowngradesSolid Biosciences (SLDB)Buy -> Neutral$15.00 -> $7.50High    
5/14/2019Chardan CapitalReiteratesProfire Energy (PFIE)HoldHigh    
5/10/2019Chardan CapitalSet Price TargetArcimoto (FUV)Buy $10.00High    
5/10/2019Chardan CapitalSet Price TargetVuzix (VUZI)Buy $10.00High    
5/12/2019Chardan CapitalReiteratesCaladrius Biosciences (CLBS)Buy $6.00Medium    
5/10/2019Chardan CapitalReiteratesNovavax (NVAX)Neutral $7.00N/A    
5/8/2019Chardan CapitalReiterates22nd Century Group (XXII)Buy $11.50N/A    
5/2/2019Chardan CapitalReiteratesSeres Therapeutics (MCRB)Buy $15.00High    
5/2/2019Chardan CapitalReiteratesEvelo Biosciences (EVLO)Hold $10.00Low    
4/23/2019Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)BuyHigh    
4/26/2019Chardan CapitalReiteratesThe Medicines (MDCO)Buy -> Buy$85.00 -> $90.00High    
4/23/2019Chardan CapitalReiteratesTocagen (TOCA)BuyHigh    
4/25/2019Chardan CapitalReiteratesOncoCyte (OCX)Buy $7.75N/A    
4/23/2019Chardan CapitalInitiatesKaleido Biosciences (KLDO)Buy -> Buy $17.50Low    
4/16/2019Chardan CapitalReiteratesGenius Brands International (GNUS)BuyN/A    
4/15/2019Chardan CapitalReiteratesAssembly Biosciences (ASMB)Hold $30.00High    
4/12/2019Chardan CapitalSet Price TargetArcimoto (FUV)Buy $10.00Low    
4/12/2019Chardan CapitalSet Price TargetSynlogic (SYBX)Buy $20.00Medium    
4/12/2019Chardan CapitalSet Price TargetSpring Bank Pharmaceuticals (SBPH)Buy $25.00High    
4/10/2019Chardan CapitalSet Price TargetDmc Global (BOOM)Buy$62.00 -> $79.00Low    
4/7/2019Chardan CapitalReiteratesModerna (MRNA)BuyLow    
4/9/2019Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)Buy $150.00Medium    
4/7/2019Chardan CapitalInitiatesSmith Micro Software (SMSI)Buy $5.00High    
4/5/2019Chardan CapitalInitiatesModerna (MRNA)Buy -> Buy $40.00High    
4/2/2019Chardan CapitalReiteratesOncoCyte (OCX)BuyLow    
4/2/2019Chardan CapitalReiteratesOncoCyte (OCX)Buy $8.00N/A    
4/2/2019Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)Buy $20.00High    
3/29/2019Chardan CapitalReiteratesKrystal Biotech (KRYS)Buy $57.50High    
3/26/2019Chardan CapitalInitiatesExicure (XCUR)Buy $5.00Medium    
3/21/2019Chardan CapitalReiteratesWrap Technologies (WRTC)Buy $12.50Medium    
3/13/2019Chardan CapitalReiteratesVascular Biogenics (VBLT)NeutralLow    
3/13/2019Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)BuyMedium    
3/19/2019Chardan CapitalSet Price TargetArcimoto (FUV)Buy $10.00High    
3/19/2019Chardan CapitalSet Price TargetVascular Biogenics (VBLT)Hold $3.00High    
3/19/2019Chardan CapitalReiteratesArcturus Therapeutics (ARCT)Buy $18.00Medium    
3/15/2019Chardan CapitalReiterates22nd Century Group (XXII)Buy $11.50N/A    
3/14/2019Chardan CapitalReiteratesEsperion Therapeutics (ESPR)Hold $50.00Medium    
3/12/2019Chardan CapitalRaises TargetKrystal Biotech (KRYS)Buy$50.00 -> $57.50Low    
3/12/2019Chardan CapitalReiteratesSynlogic (SYBX)Buy $20.00High    
3/12/2019Chardan CapitalDowngradesProfire Energy (PFIE)Buy -> NeutralLow    
3/12/2019Chardan CapitalReiteratesProQR Therapeutics (PRQR)Buy -> Buy$21.00 -> $25.00High    
3/11/2019Chardan CapitalUpgradesAxovant Gene Therapies (AXGT)Neutral -> Buy $32.00High    
3/10/2019Chardan CapitalReiteratesArbutus Biopharma (ABUS)Buy $6.50High    
3/4/2019Chardan CapitalRaises TargetUniqure (QURE)Buy$70.00 -> $100.00Low    
3/4/2019Chardan CapitalInitiatesInVitae (NVTA)Buy -> Buy $29.00Low    
2/28/2019Chardan CapitalReiteratesIovance Biotherapeutics (IOVA)Buy -> Buy$30.00 -> $20.00High    
2/28/2019Chardan CapitalDowngradesORBCOMM (ORBC)Buy -> NeutralHigh    
2/27/2019Chardan CapitalReiteratesIntellia Therapeutics (NTLA)Buy $57.50High    
2/27/2019Chardan CapitalRaises TargetMeiraGTx (MGTX)Buy -> Buy$30.00 -> $40.00High    
2/25/2019Chardan CapitalUpgradesAudentes Therapeutics (BOLD)Neutral -> Buy$35.00 -> $40.00High    
2/22/2019Chardan CapitalSet Price TargetEmergent Biosolutions (EBS)Buy $71.00High    
2/20/2019Chardan CapitalInitiatesKodiak Sciences (KOD)Buy -> Buy $22.50Medium    
2/20/2019Chardan CapitalDowngradesIrhythm Technologies (IRTC)Buy -> Neutral$111.00 -> $104.00Low    
2/15/2019Chardan CapitalReiteratesEvelo Biosciences (EVLO)Hold $10.00Medium    
2/12/2019Chardan CapitalReiteratesWrap Technologies (WRTC)BuyLow    
2/11/2019Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)Buy $24.50High    
2/11/2019Chardan CapitalDowngradesVocera Communications (VCRA)Buy -> Neutral$46.00 -> $33.00High    
2/8/2019Chardan CapitalInitiatesWrap Technologies (WRTC)Buy -> Buy $12.50High    
2/7/2019Chardan CapitalReiteratesSolid Biosciences (SLDB)Buy $15.00High    
2/7/2019Chardan CapitalReiteratesHealthequity (HQY)Buy -> Buy$82.00 -> $78.00High    
2/1/2019Chardan CapitalReiteratesTivity Health (TVTY)Buy -> Buy$41.00 -> $31.00Low    
1/31/2019Chardan CapitalReiteratesMeiraGTx (MGTX)Buy $30.00High    
1/29/2019Chardan CapitalInitiatesEvelo Biosciences (EVLO)Neutral $10.00Low    
1/24/2019Chardan CapitalReiterateseHealth (EHTH)Buy -> Buy$40.00 -> $65.00High    
1/22/2019Chardan CapitalReiteratesEditas Medicine (EDIT)Buy $55.00High    
1/22/2019Chardan CapitalUpgradesDicerna Pharmaceuticals (DRNA)Neutral -> Buy $18.00Low    
1/10/2019Chardan CapitalReiteratesVoyager Therapeutics (VYGR)NeutralMedium    
1/7/2019Chardan CapitalReiteratesProQR Therapeutics (PRQR)Buy $21.00High    
1/4/2019Chardan CapitalReiteratesRegenxbio (RGNX)Buy $127.50High    
12/20/2018Chardan CapitalReiteratesCatalyst Biosciences (CBIO)Buy $35.00High    
12/17/2018Chardan CapitalReiteratesRegenxbio (RGNX)Buy -> Buy $127.50High    
12/17/2018Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)Buy $24.50Low    
12/13/2018Chardan CapitalInitiatesSynlogic (SYBX)Buy -> Buy $20.00Medium    
12/3/2018Chardan CapitalReiteratesUniqure (QURE)Buy $70.00Medium    
11/30/2018Chardan CapitalSet Price TargetSpring Bank Pharmaceuticals (SBPH)Buy $45.00High    
11/28/2018Chardan CapitalInitiatesArcimoto (FUV)BuyHigh    
11/20/2018Chardan CapitalReiteratesVascular Biogenics (VBLT)Hold $3.00Medium    
11/13/2018Chardan CapitalInitiatesLogicBio Therapeutics (LOGC)Buy -> Buy $20.00Low    
11/7/2018Chardan CapitalRaises TargetUniqure (QURE)Buy$50.00 -> $70.00Low    
11/7/2018Chardan CapitalRaises TargetTabula Rasa HealthCare (TRHC)Buy$77.00 -> $91.00High    
11/6/2018Chardan CapitalLowers TargetTivity Health (TVTY)Buy$43.00 -> $41.00High    
11/2/2018Chardan CapitalRaises TargetTeladoc Health (TDOC)Buy -> Buy$98.00 -> $100.00High    
11/2/2018Chardan CapitalReiteratesAdverum Biotechnologies (ADVM)Hold $4.50High    
10/28/2018Chardan CapitalReiteratesSpring Bank Pharmaceuticals (SBPH)BuyHigh    
10/28/2018Chardan CapitalReiteratesSeres Therapeutics (MCRB)BuyMedium    
10/28/2018Chardan CapitalReiteratesAssembly Biosciences (ASMB)NeutralHigh    
10/22/2018Chardan CapitalInitiatesSeres Therapeutics (MCRB)Buy -> Buy $15.00Low    
10/18/2018Chardan CapitalReiteratesUniqure (QURE)Buy $50.00High    
10/16/2018Chardan CapitalReiteratesMeiraGTx (MGTX)Buy $30.00High    
10/14/2018Chardan CapitalSet Price TargetArrowhead Pharmaceuticals (ARWR)Buy $25.00Low    
10/12/2018Chardan CapitalReiteratesAmicus Therapeutics (FOLD)Hold $15.00High    
10/12/2018Chardan CapitalLowers TargetArbutus Biopharma (ABUS)Buy$12.00 -> $6.50Medium    
9/24/2018Chardan CapitalUpgradesKVH Industries (KVHI)Neutral -> Buy $20.00High    
9/13/2018Chardan CapitalInitiatesHMS (HMSY)Neutral -> Neutral $35.00Medium    
9/11/2018Chardan CapitalDowngradesApplied Genetic Technologies (AGTC)Buy -> Neutral$10.00 -> $5.00High    
9/6/2018Chardan CapitalRaises TargetArrowhead Pharmaceuticals (ARWR)Buy -> Buy$17.50 -> $24.50Medium    
9/6/2018Chardan CapitalInitiatesIrhythm Technologies (IRTC)Buy -> Buy $117.00Medium    
9/4/2018Chardan CapitalRaises TargetEmergent Biosolutions (EBS)Buy -> Buy$60.00 -> $66.00Medium    
9/4/2018Chardan CapitalInitiatesR1 RCM (RCM)Buy -> Buy $17.00High    
8/29/2018Chardan CapitalReiteratesCaladrius Biosciences (CLBS)BuyHigh    
8/29/2018Chardan CapitalReiteratesAstrotech (ASTC)BuyMedium    
8/30/2018Chardan CapitalInitiatesTocagen (TOCA)Buy -> Buy $30.00High    
8/24/2018Chardan CapitalReiteratesIntellia Therapeutics (NTLA)Buy $57.50Low    
8/23/2018Chardan CapitalInitiatesMeiraGTx (MGTX)BuyHigh    
8/17/2018Chardan CapitalDowngradesAmicus Therapeutics (FOLD)Buy -> Neutral$18.00 -> $15.00Medium    
8/16/2018Chardan CapitalInitiateseHealth (EHTH)Buy $40.00High    
8/14/2018Chardan CapitalDowngradesSunworks (SUNW)Buy -> NeutralHigh    
8/13/2018Chardan CapitalReiteratesArrowhead Pharmaceuticals (ARWR)Buy $17.50Medium    
8/13/2018Chardan CapitalReiteratesDicerna Pharmaceuticals (DRNA)Hold $14.50Low    
8/13/2018Chardan CapitalReiteratesProQR Therapeutics (PRQR)Buy $9.00Medium    
8/10/2018Chardan CapitalSet Price TargetVuzix (VUZI)Buy $10.00N/A    
8/9/2018Chardan CapitalDowngradesGlobalstar (GSAT)Buy -> NeutralLow    
8/9/2018Chardan CapitalReiteratesAdverum Biotechnologies (ADVM)Hold $8.00High    
8/9/2018Chardan CapitalDowngradesGlobalstar (GSAT)Buy -> Neutral $2.50N/A    
8/8/2018Chardan CapitalLowers TargetRegenxbio (RGNX)Buy$130.00 -> $127.50High    
8/8/2018Chardan CapitalRaises TargetSpark Therapeutics (ONCE)Neutral$60.00 -> $85.00Medium    
8/8/2018Chardan CapitalReiteratesCrispr Therapeutics (CRSP)Buy $72.50High    
8/6/2018Chardan CapitalReiteratesKrystal Biotech (KRYS)Buy $35.00High    
8/3/2018Chardan CapitalRaises TargetBenefitfocus (BNFT)Neutral$34.00 -> $36.00Medium    
8/3/2018Chardan CapitalReiteratesAlnylam Pharmaceuticals (ALNY)Buy $180.00High    

This page was last refreshed on Friday at 12:16 AM ET.

MarketBeat Community Rating for Chardan Capital

Community Ranking:  1.9 out of 5 (star half star)
Outperform Votes:  17,641 (Vote Outperform)
Underperform Votes:  28,116 (Vote Underperform)
Total Votes:  45,757
MarketBeat's community ratings are surveys of what our community members think about Chardan Capital and other research firms. Vote "Outperform" if you believe Chardan Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Chardan Capital's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel